ReviewDiabetes & metabolic syndrome
Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and India.
Review in Diabetes & metabolic syndrome. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
50 citing papers in PubMed, 134 citations in OpenAlex.
- Restoring life expectancy in low-income countries: the combined impact of COVID-19, health expenditure, GDP, and child mortality.BMC public health · 2025Article
- Economic impact of COVID-19 on patients with type 2 diabetes in Kenya and Tanzania: a costing analysis.BMJ public health · 2024Article
- Assessment of Direct Medical Cost of Hospitalized COVID-19 Adult Patients in Kuwait During the First Wave of the Pandemic.ClinicoEconomics and outcomes research : CEOR · 2024Article
- Prospective Study of Incidence and Impact of Comorbidities on Breast Cancer Survival from India.Asian Pacific journal of cancer prevention : APJCP · 2023Observational
- The Rise and Fall of Omicron BA.1 Variant as Seen in Wastewater Supports Epidemiological Model Predictions.Viruses · 2023Article
- Perspective of healthcare providers on assessing the quality and accessibility of health services for chronic diseases in Jordan during Covid-19: a mixed method study.BMC health services research · 2023Article
- Quantitative Framework for Establishing Low-Risk Inter-District Travel Corridors During COVID-19.Transportation research record · 2023Article
- The Pattern of COVID-19 in Horn of Africa countries, from March-December 2020.African health sciences · 2023Article
- Association of Alleles of Human Leukocyte Antigen Class II Genes and Severity of COVID-19 in Patients of the 'Red Zone' of the Endocrinology Research Center, Moscow, Russia.Diseases (Basel, Switzerland) · 2022Article
- The impact of COVID-related economic shocks on household mental health in Pakistan.Health economics · 2022Article
- A critical evaluation of risk to reward ratio of quercetin supplementation for COVID-19 and associated comorbid conditions.Phytotherapy research : PTR · 2022Review
- Early prediction of SARS-CoV-2 reproductive number from environmental, atmospheric and mobility data: A supervised machine learning approach.International journal of medical informatics · 2022Article
- Review
- Cellular heterogeneity in disease severity and clinical outcome: Granular understanding of immune response is key.Frontiers in immunology · 2022Review
- Deviation in the Age Structure of Mortality as an Indicator of COVID-19 Pandemic Severity.American journal of public health · 2022Article
- Perceived risk and perceptions of COVID-19 vaccine: A survey among general public in Pakistan.PloS one · 2022Article
- Differential mortality with COVID-19 and invasive mechanical ventilation between high-income and low-and middle-income countries: a systematic review, meta-analysis, and meta-regression.Le infezioni in medicina · 2022Review
- Prevalence and Impact of Preexisting Comorbidities on Overall Clinical Outcomes of Hospitalized COVID-19 Patients.BioMed research international · 2022Article
- Modeling the Transmission Dynamics of COVID-19 Among Five High Burden African Countries.Clinical epidemiology · 2022Article
- Comparison of clinical characteristics between SARS-CoV-2 Omicron variant and Delta variant infections in China.Frontiers in medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsPresence of comorbidities in patients with Coronavirus disease 2019 (COVID-19) have often been associated with increased in-hospital complications and mortality. Intriguingly, several developed countries with a higher quality of life have relatively higher mortality with COVID-19, compared to the middle- or low-income countries. Moreover, certain ethnic groups have shown a higher predilection to contract COVID-19, with heightened mortality. We sought to review the available literature with regards to impact of COVID-19 and comorbidities on the health and economics, especially in context to the developing countries including India.
methodsA Boolean search was carried out in PubMed, MedRxiv and Google Scholar databases up till August 23, 2020 using the specific keywords, to find the prevalence of comorbidities and its outcome in patients with COVID-19.
resultsAll available evidence consistently suggests that presence of comorbidities is associated with a poor outcome in patients with COVID-19. Diabetes prevalence is highest in Indian COVID-19 patients, compared to other countries. Majority of the patients with COVID-19 are asymptomatic ranging from 26 to 76%.
conclusionsUniversal masking is the need of hour during unlock period. Low-income countries such as India, Brazil and Africa with less resources and an average socio-economic background, must adopt a strict policy for an affordable testing programs to trace, test, identify and home quarantine of asymptomatic cases. Despite the huge number of COVID-19 patients, India still has low volume research at the moment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.